# US 2025/0367151 A1 · Anti-vwf therapeutic for preventing arterial thrombi

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0367151 A1
- Document ID: US20250367151A1
- Status: Published application
- Kind: A1
- Application number: 18/875,512
- Filed: 2023-06-16
- Published: 2025-12-04
- Earliest claimed: 2022-06-16
- Assignees: Georgia Tech Research Corporation
- Applicants: Georgia Tech Research Corporation
- Inventors: David N. KU; Christopher BRESETTE
- Web page: https://patentgrep.com/patent/US20250367151A1

## CPC

- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 31/095: Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K 31/194: having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
- A61K 33/04: Sulfur, selenium or tellurium; Compounds thereof
- A61K 38/063: {Glutathione}
- A61P 7/02: Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Disclosed are methods and compositions for treating or preventing arterial thrombosis in a subject in need thereof comprising administering to the subject a thiol or selenium containing compound.

## Claims

### Claim 1

A method of preventing arterial thrombosis in a subject in need thereof, comprising: administering to the subject a thiol containing compound.

### Claim 2 (depends on 1)

The method of claim 1, wherein the thiol containing compound is N-acetyl cysteine, cysteine, dithiothreitol, glutathione, dimercaptosuccinic acid, thioterpinol, methanethiol, ethanethiol, a peptide comprising N-acetyl cysteine, or any combination thereof.

### Claim 3

(canceled)

### Claim 4

(canceled)

### Claim 5 (depends on 1)

The method of claim 1, wherein the thiol containing compound is administered at from 1 to 10 mM.

### Claim 6

(canceled)

### Claim 7 (depends on 1)

The method of claim 1, wherein the thiol containing compound is administered at from 100 to 1000 mg/kg dose.

### Claim 8

(canceled)

### Claim 9 (depends on 1)

The method of claim 1, wherein the thiol containing compound is administered once.

### Claim 10 (depends on 1)

The method of claim 1, wherein the subject is at high risk of forming arterial thrombi by having a blood concentration of vWF in an upper 4th quartile.

### Claim 11 (depends on 1)

The method of claim 1, wherein the subject is hospitalized for cardiovascular disease.

### Claim 12 (depends on 1)

The method of claim 1, wherein the subject is undergoing angioplasty or percutaneous coronary intervention, has a heart attack, or has ischemic stroke.

### Claim 13

A method of treating arterial thrombosis in a subject in need thereof, comprising:
administering to the subject a thiol containing compound.

### Claim 14 (depends on 13)

The method of claim 13, wherein the thiol containing compound is N-acetyl cysteine, cysteine, dithiothreitol, glutathione, dimercaptosuccinic acid, thioterpinol, methanethiol, ethanethiol, a peptide comprising N-acetyl cysteine, or any combination thereof.

### Claim 15

(canceled)

### Claim 16

(canceled)

### Claim 17 (depends on 13)

The method of claim 13, wherein the thiol containing compound is administered at from 1 to 10 mM.

### Claim 18

(canceled)

### Claim 19 (depends on 13)

The method of claim 13, wherein the thiol containing compound is administered at from 100 to 1000 mg/kg dose.

### Claim 20

(canceled)

### Claim 21 (depends on 13)

The method of claim 13, wherein the thiol containing compound is administered once.

### Claim 22 (depends on 13)

The method of claim 13, wherein the subject is at high risk of forming arterial thrombi by having a blood concentration of vWF in an upper 4th quartile.

### Claim 23 (depends on 13)

The method of claim 13, wherein the subject is hospitalized for cardiovascular disease.

### Claim 24 (depends on 13)

The method of claim 13, wherein the subject is undergoing angioplasty or percutaneous coronary intervention, has a heart attack, or has ischemic stroke.

### Claim 25

A method of reducing thrombi formation in an artery, comprising: administering to the artery an effective amount of a thiol containing compound.

### Claim 26 (depends on 25)

The method of claim 25, wherein the thiol containing compound is N-acetyl cysteine, cysteine, dithiothreitol, glutathione, dimercaptosuccinic acid, thioterpinol, methanethiol, ethanethiol, a peptide comprising N-acetyl cysteine, or any combination thereof.

### Claim 27

(canceled)

### Claim 28

(canceled)

### Claim 29 (depends on 25)

The method of claim 25, wherein the thiol containing compound is administered at from 1 to 10 mM.

### Claim 30

(canceled)

### Claim 31 (depends on 25)

The method of claim 25, wherein the thiol containing compound is administered at from 100 to 1000 mg/kg dose.

### Claim 32

(canceled)

### Claim 33 (depends on 25)

The method of claim 25, wherein the thiol containing compound is administered once.

### Claim 34 (depends on 25)

The method of claim 25, wherein the artery is in a subject at high risk of forming arterial thrombi by having a blood concentration of vWF in an upper 4th quartile.

### Claim 35 (depends on 25)

The method of claim 25, wherein the artery is in a subject hospitalized for cardiovascular disease.

### Claim 36 (depends on 25)

The method of claim 25, wherein the artery is in a subject undergoing angioplasty or percutaneous coronary intervention, has a heart attack, or has ischemic stroke.

### Claim at position 37

37-39. (canceled)
